MEDIP PRO

Medip Pro is medical image processing software designed to convert DICOM images from CT and MRI scans into 3D visualizations and exportable STL files for creating non-diagnostic 3D printed models, aiding in pre-operative treatment planning. The software utilizes advanced image processing techniques including segmentation, 3D reconstruction, image enhancement, and texture analysis, with its performance validated through non-clinical testing.

Medip Pro is medical image processing software designed to facilitate pre-operative treatment planning by converting DICOM imaging data from CT or MRI scanners into manipulable digital formats. Its primary function is to act as a software interface and image segmentation system, transferring medical imaging information to an output file suitable for generating 3D printed anatomical models, which are strictly intended for non-diagnostic purposes and must be used alongside other diagnostic tools and expert clinical judgment. The software achieves this through functionalities such as 3D reconstruction and visualization of regions of interest, advanced image quality improvement, automated segmentation of specific targets, and texture analysis. Medip Pro supports the export of data in STL format, commonly used for 3D printing. The device's performance and safety were assessed through non-clinical software validation, including verification and validation of software subsystems and the integrated system, and comparative performance tests against predicate devices, focusing on segmentation accuracy and measurement capabilities using phantom studies and usability testing. No clinical studies were conducted as part of its evaluation.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. Regarding the 'advanced image quality improvement' feature, what specific algorithms are employed, and how is their efficacy quantitatively benchmarked beyond general software validation?; The document states 'auto segmentation for specific target.' Which anatomical targets are supported, what is the validated accuracy range for these automated segmentations, and what is the typical computational time?; How does the 'texture analysis' functionality concretely assist in pre-operative treatment planning, and are there specific clinical scenarios or tissue characteristics where this feature provides unique insights not available from standard imaging?; For the non-diagnostic 3D printed models, what is the expected geometric fidelity of the STL output relative to the source DICOM data, and what validation methods were used to confirm this accuracy for complex anatomical structures?; Given the absence of clinical studies, what post-market strategies are planned to evaluate the real-world impact of Medip Pro on surgical planning efficiency, intraoperative decision-making, or patient outcomes when used as intended?